Publication Name	World Journal of Meta-Analysis
Manuscript ID	63583
Country	Iran

Received	2021-01-29 20:36
Peer-Review Started	2021-01-29 20:48
To Make the First Decision
Return for Revision	2021-03-15 16:10
Revised	2021-03-17 05:29
Second Decision	2021-04-23 07:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-23 11:50
Articles in Press	2021-04-23 11:50
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-04-27 04:15
Typeset the Manuscript	2021-04-28 00:49
Publish the Manuscript Online	2021-04-28 12:31

ISSN	2308-3840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration
Manuscript Source	Invited Manuscript
All Author List	Haleh Ashraf, Shahrokh Karbalai and Raika Jamali
ORCID	Author(s) ORCID Number Haleh Ashraf http://orcid.org/0000-0001-6687-995X Shahrokh Karbalai http://orcid.org/0000-0002-7488-6188 Raika Jamali http://orcid.org/0000-0002-6185-7185
Funding Agency and Grant Number
Corresponding Author	Raika Jamali, MD, Associate Professor, Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Imam Khomeini St. Hassan Abad Sq., Sina Hospital, Tehran 1938934131, Iran. jamalira@tums.ac.ir
Key Words	Non-alcoholic steatohepatitis; Cardiovascular disease; Screening; Atherosclerosis; Risk scores; Metabolic syndrome
Core Tip	The diagnosis of nonalcoholic fatty liver disease (NAFLD) deserves a thoughtful cardiovascular risk assessment and evaluation for subclinical atherosclerosis to prevent cardiovascular disease (CVD) morbidity/mortality. In Patients with non-alcoholic steatohepatitis-related cirrhosis undergoing liver transplantation, screening for significant CAD should be done by stress echocardiography and computed tomography coronary angiography. Recommendation for screening in asymptomatic NAFLD without significant fibrosis is not clear. The basis of NAFLD prevention and treatment is lifestyle modifications, while concomitant cardiovascular risk factors should be targeted.
Publish Date	2021-04-28 12:31
Citation	Ashraf H, Karbalai S, Jamali R. Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration. World J Meta-Anal 2021; 9(2): 164-175
URL	https://www.wjgnet.com/2308-3840/full/v9/i2/164.htm
DOI	https://dx.doi.org/10.13105/wjma.v9.i2.164

Full Article (PDF)	WJMA-9-164.pdf
Full Article (Word)	WJMA-9-164.docx
Manuscript File	63583-Review-FilipodiaCL.docx
Answering Reviewers	63583-Answering reviewers.pdf
Audio Core Tip	63583-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63583-Conflict-of-interest statement.pdf
Copyright License Agreement	63583-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	63583-Language certificate.pdf
Peer-review Report	63583-Peer-review(s).pdf
Scientific Misconduct Check	63583-Scientific misconduct check.pdf
Scientific Editor Work List	63583-Scientific editor work list.pdf